Stock listing
Munich:LSR Cel-Sci Corporation Aktie
German listing (Munich) of Cel-Sci Corporation · home listing NYSE American:CVM
Follow Cel-Sci Corporation into a list and get an email when it puts out news.
Home listing price · AMEX:CVM
$1.38 USD -0.12 (-8.0%)
Close on Oct 30, 2026 · This listing has no price on 6ix; the price shown is the home listing's, AMEX:CVM
- Day range
- $1.36 – $1.47 USDOct 30, 2026
- Volume
- 188,992 sharesOct 30, 2026
- Market cap
- $24.27M USDAt the close on Oct 30, 2026 · price × 17.59M shares outstanding
- 52-week range
- $0.89 – $7.80 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $353,256 USDMedian day 137,300 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:CVM · Home | $1.38 USD | -0.12 (-8.0%) | 188,992 | $1.47 | $1.47 | $1.36 | $1.50 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · AMEX:CVM · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.38 | -0.12 | -8.0% | $1.47 | $1.47 | $1.36 | 188,992 | |
| $1.50 | -0.10 | -6.3% | $1.56 | $1.64 | $1.50 | 77,900 | |
| $1.60 | +0.03 | +1.9% | $1.54 | $1.60 | $1.52 | 98,354 | |
| $1.57 | -0.02 | -1.3% | $1.58 | $1.60 | $1.46 | 117,638 | |
| $1.59 | -0.05 | -3.0% | $1.71 | $1.83 | $1.51 | 106,665 | |
| $1.64 | +0.03 | +1.9% | $1.59 | $1.64 | $1.57 | 41,900 | |
| $1.61 | -0.01 | -0.6% | $1.61 | $1.65 | $1.58 | 78,500 | |
| $1.62 | +0.07 | +4.5% | $1.56 | $1.62 | $1.50 | 149,400 | |
| $1.55 | -0.10 | -6.1% | $1.65 | $1.66 | $1.54 | 140,500 | |
| $1.65 | -0.14 | -7.8% | $1.79 | $1.81 | $1.60 | 129,900 | |
| $1.79 | +0.05 | +2.9% | $1.78 | $1.93 | $1.75 | 168,200 | |
| $1.74 | +0.03 | +1.8% | $1.69 | $1.78 | $1.66 | 72,000 | |
| $1.71 | -0.04 | -2.3% | $1.73 | $1.75 | $1.68 | 105,700 | |
| $1.75 | -0.08 | -4.4% | $1.84 | $1.84 | $1.71 | 224,600 | |
| $1.83 | -0.11 | -5.7% | $1.95 | $1.97 | $1.76 | 357,200 | |
| $1.94 | -0.01 | -0.5% | $1.96 | $1.98 | $1.83 | 255,400 | |
| $1.95 | -0.18 | -8.5% | $2.10 | $2.25 | $1.92 | 385,500 | |
| $2.13 | -0.61 | -22.3% | $2.74 | $2.77 | $2.07 | 661,100 | |
| $2.74 | +0.32 | +13.2% | $2.42 | $2.83 | $2.29 | 470,100 | |
| $2.42 | +0.11 | +4.8% | $2.39 | $2.75 | $2.35 | 796,100 | |
| $2.31 | +0.22 | +10.5% | $2.14 | $2.31 | $2.03 | 387,500 | |
| $2.09 | +0.03 | +1.5% | $2.06 | $2.30 | $1.96 | 807,600 | |
| $2.06 | +0.27 | +15.1% | $1.80 | $2.09 | $1.78 | 474,000 | |
| $1.79 | +0.09 | +5.3% | $1.70 | $1.79 | $1.70 | 74,500 | |
| $1.70 | +0.03 | +1.8% | $1.67 | $1.72 | $1.67 | 126,200 | |
| $1.67 | -0.05 | -2.9% | $1.70 | $1.71 | $1.67 | 36,400 | |
| $1.72 | +0.04 | +2.4% | $1.70 | $1.76 | $1.68 | 56,100 | |
| $1.68 | -0.02 | -1.2% | $1.69 | $1.76 | $1.68 | 171,400 | |
| $1.70 | +0.03 | +1.8% | $1.70 | $1.73 | $1.66 | 133,800 | |
| $1.67 | +0.01 | +0.6% | $1.71 | $1.75 | $1.66 | 109,600 | |
| $1.66 | +0.17 | +11.4% | $1.53 | $1.70 | $1.51 | 265,000 | |
| $1.49 | +0.01 | +0.7% | $1.51 | $1.57 | $1.49 | 43,200 | |
| $1.48 | 0.00 | 0.0% | $1.50 | $1.53 | $1.47 | 71,400 | |
| $1.48 | -0.04 | -2.6% | $1.53 | $1.54 | $1.47 | 94,700 | |
| $1.52 | +0.03 | +2.0% | $1.46 | $1.56 | $1.46 | 66,500 | |
| $1.49 | -0.03 | -2.0% | $1.55 | $1.55 | $1.46 | 98,500 | |
| $1.52 | -0.02 | -1.3% | $1.57 | $1.58 | $1.51 | 75,900 | |
| $1.54 | -0.11 | -6.7% | $1.67 | $1.67 | $1.54 | 85,800 | |
| $1.65 | +0.02 | +1.2% | $1.64 | $1.77 | $1.64 | 283,300 | |
| $1.63 | +0.02 | +1.2% | $1.61 | $1.63 | $1.58 | 75,100 | |
| $1.61 | -0.04 | -2.4% | $1.65 | $1.68 | $1.60 | 116,100 | |
| $1.65 | +0.04 | +2.5% | $1.64 | $1.70 | $1.60 | 134,100 | |
| $1.61 | -0.01 | -0.6% | $1.60 | $1.63 | $1.57 | 70,000 | |
| $1.62 | +0.06 | +3.8% | $1.59 | $1.62 | $1.54 | 55,700 | |
| $1.56 | -0.04 | -2.5% | $1.61 | $1.61 | $1.53 | 169,400 | |
| $1.60 | -0.01 | -0.6% | $1.60 | $1.69 | $1.57 | 161,000 | |
| $1.61 | +0.13 | +8.8% | $1.55 | $1.70 | $1.53 | 262,300 | |
| $1.48 | +0.10 | +7.2% | $1.40 | $1.50 | $1.37 | 86,400 | |
| $1.38 | -0.04 | -2.8% | $1.42 | $1.43 | $1.34 | 147,700 | |
| $1.42 | -0.04 | -2.7% | $1.48 | $1.49 | $1.42 | 66,100 | |
| $1.46 | -0.18 | -11.0% | $1.62 | $1.64 | $1.45 | 183,500 | |
| $1.64 | +0.05 | +3.1% | $1.61 | $1.69 | $1.59 | 184,700 | |
| $1.59 | +0.04 | +2.6% | $1.57 | $1.68 | $1.55 | 228,700 | |
| $1.55 | +0.01 | +0.6% | $1.60 | $1.63 | $1.45 | 129,400 | |
| $1.54 | +0.05 | +3.4% | $1.52 | $1.64 | $1.52 | 218,400 | |
| $1.49 | +0.01 | +0.7% | $1.48 | $1.49 | $1.45 | 57,200 | |
| $1.48 | -0.04 | -2.6% | $1.51 | $1.54 | $1.45 | 152,700 | |
| $1.52 | +0.03 | +2.0% | $1.47 | $1.54 | $1.47 | 103,800 | |
| $1.49 | -0.23 | -13.4% | $1.71 | $1.75 | $1.46 | 325,500 | |
| $1.72 | +0.11 | +6.8% | $1.63 | $1.73 | $1.57 | 249,500 | |
| $1.61 | +0.09 | +5.9% | $1.55 | $1.62 | $1.50 | 268,700 | |
| $1.52 | +0.16 | +11.8% | $1.36 | $1.54 | $1.36 | 404,400 | |
| $1.36 | +0.11 | +8.8% | $1.25 | $1.39 | $1.25 | 269,900 | |
| $1.25 | +0.09 | +7.8% | $1.21 | $1.31 | $1.15 | 668,400 | |
| $1.16 | -0.06 | -4.9% | $1.22 | $1.22 | $1.16 | 165,600 | |
| $1.22 | +0.08 | +7.0% | $1.15 | $1.24 | $1.15 | 128,600 |
- Ticker
- Munich:LSR
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Munich
- Currency
- EUR
What changed lately
Latest news release · Oct 26, 2026
CEL-SCI Presents New Phase 3 Multikine® Data at World Congress: Pre-Surgical Biomarkers Identify Head & Neck Cancer Patients Achieving 73% 5-Year Survival
Latest deck · September 2026
Investor Presentation (September 2026)
Investor deck · 21 slides
Latest news
CEL-SCI Presents New Phase 3 Multikine® Data at World Congress: Pre-Surgical Biomarkers Identify Head & Neck Cancer Patients Achieving 73% 5-Year Survival
Oct 26, 2026
Closed $1.59 (-3.0%) on Oct 26, 2026
CEL-SCI Reports Fiscal Third Quarter 2026 Results
Aug 17, 2026
Closed $1.55 (+0.6%) on Aug 17, 2026
Cel-Sci: Fiscal Q3 Earnings Snapshot
Aug 14, 2026
Closed $1.55 (+0.6%) on Aug 17, 2026
CEL-SCI to Launch FDA Registration-Enabling Phase 3 Confirmatory Study to Bring Multikine® to Market for Newly Diagnosed Head and Neck Cancer
Jul 13, 2026
Closed $1.22 (-11.6%) on Jul 13, 2026
CEL-SCI Announces Closing of Offering
Jun 16, 2026
Closed $1.10 (+8.9%) on Jun 17, 2026
CEL-SCI Advances Multikine® Immunotherapy for Head and Neck Cancer Through Dual U.S. Registration Study and Saudi Market Entry Strategy
Jun 16, 2026
Closed $1.01 (0.0%) on Jun 16, 2026
CEL-SCI Corporation Announces Pricing of Offering
Jun 14, 2026
Closed $1.01 (-6.5%) on Jun 15, 2026
CEL-SCI Reports Fiscal Second Quarter 2026 Results
May 18, 2026
Closed $1.72 (+20.3%) on May 18, 2026
Cel-Sci: Fiscal Q2 Earnings Snapshot
May 15, 2026
Closed $1.72 (+20.3%) on May 18, 2026
CEL-SCI Corporation Announces Pricing of Public Offering
May 11, 2026
Closed $1.19 (-15.6%) on May 12, 2026
Decks
Investor Presentation (September 2026)
Investor deck · 21 slides · September 2026
Investor Presentation (September 2026)
Investor deck · 22 slides · September 2026
Investor Presentation (August 2026)
Investor deck · 22 slides · August 2026
Investor Presentation (July 2026)
Investor deck · 21 slides · July 2026
Cel-Sci Corporation on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 14 in the last 12 months · 30 in all · newest Oct 26, 2026 · oldest 2025
- Decks
- 55 decks · latest September 2026
Where Cel-Sci Corporation is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:CVM · Home listing | NYSE American | United States | USD |
| gettex:LSR | gettex | Germany | EUR |
| BOATS:CVM | BOATS | United States | USD |
| Munich:LSR · This page | Munich | Germany | EUR |
| Frankfurt:LSR | Frankfurt | Germany | EUR |
| Lang & Schwarz:A418TV | Lang & Schwarz | Germany | EUR |
| LS Exchange:A418TV | LS Exchange | Germany | EUR |
Log in to ask 6ix AI your own questions about Cel-Sci Corporation.